2-phosphonobutane-1,2,4-tricarboxylic acid

dental plaque crystal growth inhibitor; RN given for parent cpd; structure given in first source

Also Known As:

2-phosphonobutane-1,2,4-tricarboxylic acid, sodium salt; 2-phosphonobutane-1,2,4-tricarboxylic acid, trisodium salt; PBTA; PBTC tricarboxylic acid

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 11/01/2023 - "• Tumor density in the venous phase, tumor necrosis, splenic vein invasion, adjacent organ invasion, and superior mesenteric vein/portal vein abutment were associated with RFS in patients with resectable PBTA. " 01/01/2017 - "Pancreatic body and tail adenocarcinoma (PBTA) remains one of the deadliest cancers, and current radiological modalities still have limitations on the staging of PBTA. "
2.	Adenocarcinoma 11/01/2023 - "To identify prognostic CT features that predict recurrence in patients with resectable pancreatic body/tail adenocarcinoma (PBTA) and construct a CT-based nomogram for preoperative risk stratification. " 01/01/2017 - "Pancreatic body and tail adenocarcinoma (PBTA) remains one of the deadliest cancers, and current radiological modalities still have limitations on the staging of PBTA. "
3.	Poisoning 10/15/2022 - "Herein we demonstrate the inclusion of a commercial antiscalant 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTC) can prevent both scale formation and Cl- poisoning, leading to an efficient and steady EHDC process. "
4.	Necrosis 11/01/2023 - "• Tumor density in the venous phase, tumor necrosis, splenic vein invasion, adjacent organ invasion, and superior mesenteric vein/portal vein abutment were associated with RFS in patients with resectable PBTA. "
5.	Calculi (Calculus) 01/01/1985 - "One percent solution of PBTA was evaluated in a rat calculus assay. "

1.	Solutions